AMERICAN LITHIUM CORP (AMLI)

CA0272592092 - Common Stock

0.36  0 (0%)

Fundamental Rating

2

Taking everything into account, AMLI scores 2 out of 10 in our fundamental rating. AMLI was compared to 155 industry peers in the Metals & Mining industry. While AMLI seems to be doing ok healthwise, there are quite some concerns on its profitability. AMLI has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

In the past year AMLI has reported negative net income.
AMLI had a negative operating cash flow in the past year.
In the past 5 years AMLI always reported negative net income.
AMLI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AMLI has a worse Return On Assets (-19.16%) than 78.06% of its industry peers.
AMLI's Return On Equity of -19.52% is on the low side compared to the rest of the industry. AMLI is outperformed by 70.97% of its industry peers.
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROIC N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AMLI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

AMLI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMLI has more shares outstanding
The debt/assets ratio for AMLI has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 21.42 indicates that AMLI is not in any danger for bankruptcy at the moment.
The Altman-Z score of AMLI (21.42) is better than 87.10% of its industry peers.
AMLI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, AMLI belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.42
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AMLI has a Current Ratio of 4.22. This indicates that AMLI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 4.22, AMLI is doing good in the industry, outperforming 75.48% of the companies in the same industry.
A Quick Ratio of 4.22 indicates that AMLI has no problem at all paying its short term obligations.
AMLI's Quick ratio of 4.22 is fine compared to the rest of the industry. AMLI outperforms 78.06% of its industry peers.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 4.22

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.74% over the past year.
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 12.88% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMLI. In the last year negative earnings were reported.
Also next year AMLI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

AMLI's earnings are expected to grow with 12.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.25%
EPS Next 3Y12.88%

0

5. Dividend

5.1 Amount

No dividends for AMLI!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN LITHIUM CORP

NASDAQ:AMLI (12/23/2024, 9:42:59 AM)

0.36

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)N/A N/A
Inst Owners8.38%
Inst Owner ChangeN/A
Ins Owners4.23%
Ins Owner ChangeN/A
Market Cap78.45M
Analysts86
Price Target3.16 (777.78%)
Short Float %0.56%
Short Ratio1.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.2%
PT rev (3m)-0.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)44.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.22
Quick Ratio 4.22
Altman-Z 21.42
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2061.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.08%
EBIT Next 3Y-6.13%
EBIT Next 5YN/A
FCF growth 1Y26.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.39%
OCF growth 3YN/A
OCF growth 5YN/A